Trial Outcomes & Findings for CADDIE Trial - Computer Aided Diagnosis and Detection for Intelligent Endoscopy (NCT NCT04325815)
NCT ID: NCT04325815
Last Updated: 2025-02-19
Results Overview
The difference in endoscopist ADR between the intervention (CADDIE system) and non-intervention arm.
COMPLETED
739 participants
30 days
2025-02-19
Participant Flow
Participant milestones
| Measure |
CADDIE
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Overall Study
STARTED
|
368
|
371
|
|
Overall Study
COMPLETED
|
306
|
309
|
|
Overall Study
NOT COMPLETED
|
62
|
62
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
CADDIE Trial - Computer Aided Diagnosis and Detection for Intelligent Endoscopy
Baseline characteristics by cohort
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
Total
n=615 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
176 Participants
n=5 Participants
|
201 Participants
n=7 Participants
|
377 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
130 Participants
n=5 Participants
|
108 Participants
n=7 Participants
|
238 Participants
n=5 Participants
|
|
Age, Continuous
|
59.4 years
STANDARD_DEVIATION 14.7 • n=5 Participants
|
58.0 years
STANDARD_DEVIATION 14.8 • n=7 Participants
|
58.7 years
STANDARD_DEVIATION 14.7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
159 Participants
n=5 Participants
|
156 Participants
n=7 Participants
|
315 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
147 Participants
n=5 Participants
|
153 Participants
n=7 Participants
|
300 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · White British/Irish
|
226 Participants
n=5 Participants
|
247 Participants
n=7 Participants
|
473 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · White European
|
21 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · Mixed race
|
3 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · South East Asian
|
24 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
35 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · Asian Chinese
|
3 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · Asian Other
|
6 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · Black
|
4 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · Jewish
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · Arab
|
5 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Ethnicity/Race · Other
|
13 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
23 Participants
n=5 Participants
|
|
Region of Enrollment
United Kingdom
|
306 participants
n=5 Participants
|
309 participants
n=7 Participants
|
615 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 30 daysThe difference in endoscopist ADR between the intervention (CADDIE system) and non-intervention arm.
Outcome measures
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
To Evaluate Whether Using the CADDIE System Improves Endoscopist Detection of Adenomas During Colonoscopy.
|
33.30 ADR (% of participants)
|
25.20 ADR (% of participants)
|
SECONDARY outcome
Timeframe: 30 daysCompare the difference in the number of adenomas detected per colonoscopy between the intervention and non-intervention arm
Outcome measures
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Evaluate the Difference in Number of Adenomas Detected Per Colonoscopy Between Intervention and Non-intervention Arm
|
0.66 Adenomas per colonoscopy
Standard Deviation 1.44
|
0.42 Adenomas per colonoscopy
Standard Deviation 0.98
|
SECONDARY outcome
Timeframe: 30 daysPolyp Detection Rate (including proximal polyp detection rate) in the interventional group compared to the control group. \- Mean number of polyps detected per colonoscopy in the interventional group compared to the control group.
Outcome measures
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
To Determine Whether the CADDIE Artificial Intelligence System Improves Endoscopic Detection of All Polyps During Colonoscopy
|
0.87 PPC
Standard Deviation 1.59
|
0.63 PPC
Standard Deviation 1.24
|
SECONDARY outcome
Timeframe: 30 daysCompare the accuracy of CADDIE against human endoscopist (high confidence diagnoses) for the optical diagnosis of diminutive polyps. Accuracy is defined as true positive and true negative divided by diagnoses total polyps that were optically diagnosed with high confidence.
Outcome measures
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Compare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)
|
87.5 % of adenomas correctly diagnosed
Interval 77.6 to 94.1
|
76.7 % of adenomas correctly diagnosed
Interval 64.3 to 86.2
|
SECONDARY outcome
Timeframe: 30 daysCompare the accuracy of using CADDIE's optical diagnosis to assign surveillance colonoscopy intervals against using human endoscopist optical diagnosis (high confidence diagnoses) for assigning surveillance colonoscopy intervals.
Outcome measures
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Compare the Accuracy of Endoscopist Optical Diagnosis to Assign Colonoscopy Surveillance Intervals When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)
|
90.9 % pts with correct surveillance interval
|
87.2 % pts with correct surveillance interval
|
SECONDARY outcome
Timeframe: 30 daysCompare the accuracy of CADDIE against human endoscopist (high confidence diagnoses) for the optical diagnosis of diminutive rectal polyps.
Outcome measures
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Compare the Accuracy of Endoscopist Optical Diagnosis of Diminutive Rectal Polyps When Using the CADDIE System (Intervention Arm) Compared to Without the CADDIE System (Control Arm)
|
73.3 % of adenomas correctly diagnosed
Interval 44.9 to 92.2
|
53.3 % of adenomas correctly diagnosed
Interval 26.6 to 78.7
|
SECONDARY outcome
Timeframe: 30 daysSafety of the device will be assessed through monitoring of adverse events for 30 days' post-procedure. Adverse events are defined as: * Abdominal pain/discomfort. * Abdominal bloating. * Sedation related aspiration. * Bleeding risk. * Perforation. * Post polypectomy electrocoagulation syndrome. * Infection.
Outcome measures
| Measure |
CADDIE
n=368 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=371 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Evaluate the Safety of the CADDIE by Recording Occurrence and Severity of Adverse Events.
|
15 AE/SAE
|
14 AE/SAE
|
SECONDARY outcome
Timeframe: 30 daysPatient response to the question 'How anxious or calm were you during the colonoscopy?' assessed by Likert Scale with 5 options - 1 (Very anxious), 2 (Somewhat anxious), 3 (Neither Anxious nor calm), 4 (Somewhat calm), 5 (Very calm).
Outcome measures
| Measure |
CADDIE
n=306 Participants
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=309 Participants
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Assess Patient Anxiety During the Colonoscopy
|
2.989 score on a scale
Standard Deviation 1.193
|
3.061 score on a scale
Standard Deviation 1.241
|
Adverse Events
CADDIE
Standard Procedure
Serious adverse events
| Measure |
CADDIE
n=368 participants at risk
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=371 participants at risk
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Musculoskeletal and connective tissue disorders
Re-admission due to fall, mechnical injury
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.27%
1/371 • Adverse events were recorded for 30 days post-procedure
|
|
Surgical and medical procedures
Operation unrelated to study design/study device
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
Gastrointestinal disorders
Gastrointestinal disorder unrelated to study device
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
Cardiac disorders
Death due to underlying cardiovascular disease
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
General disorders
Death due to index diagnosis of malignancy unrelated to study design/ study device
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
Other adverse events
| Measure |
CADDIE
n=368 participants at risk
The endoscopist will be assisted with CADDIE system to detect polyps. The endoscopist will perform optical diagnosis of polyps with the assistance of the CADDIE's polyp characterisation function.
CADDIE- Computer Aided (AI) Device used in Endoscopy:
1. CADDIE assisted polyp detection
2. CADDIE assisted polyp characterisation
|
Standard Procedure
n=371 participants at risk
In addition to routine colonoscopy the endoscopist will perform optical diagnosis of detected polyps without the assistance of the CADDIE.
|
|---|---|---|
|
Gastrointestinal disorders
Gastrointestinal disorder unrelated to study device
|
0.54%
2/368 • Adverse events were recorded for 30 days post-procedure
|
1.9%
7/371 • Adverse events were recorded for 30 days post-procedure
|
|
Musculoskeletal and connective tissue disorders
Mechanical Injury unrelated to study design/ study device
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.54%
2/371 • Adverse events were recorded for 30 days post-procedure
|
|
Renal and urinary disorders
New diagnosis Prostate cancer
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
Respiratory, thoracic and mediastinal disorders
Shortness of Breath
|
0.54%
2/368 • Adverse events were recorded for 30 days post-procedure
|
0.27%
1/371 • Adverse events were recorded for 30 days post-procedure
|
|
Nervous system disorders
Headache
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
Investigations
Electrolyte abnormality
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
Cardiac disorders
Irregular heart beat
|
0.00%
0/368 • Adverse events were recorded for 30 days post-procedure
|
0.27%
1/371 • Adverse events were recorded for 30 days post-procedure
|
|
Nervous system disorders
Dizziness
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
Nervous system disorders
Facial pain
|
0.00%
0/368 • Adverse events were recorded for 30 days post-procedure
|
0.27%
1/371 • Adverse events were recorded for 30 days post-procedure
|
|
Renal and urinary disorders
Pyelonephritis
|
0.27%
1/368 • Adverse events were recorded for 30 days post-procedure
|
0.00%
0/371 • Adverse events were recorded for 30 days post-procedure
|
|
Renal and urinary disorders
AKI
|
0.00%
0/368 • Adverse events were recorded for 30 days post-procedure
|
0.27%
1/371 • Adverse events were recorded for 30 days post-procedure
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place